↓ Skip to main content

Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors

Overview of attention for article published in Supportive Care in Cancer, May 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
99 Mendeley
citeulike
1 CiteULike
Title
Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors
Published in
Supportive Care in Cancer, May 2012
DOI 10.1007/s00520-012-1490-z
Pubmed ID
Authors

Krupali Desai, Jun J. Mao, Irene Su, Angela DeMichele, Qing Li, Sharon X. Xie, Philip R. Gehrman

Abstract

Insomnia is increasingly recognized as a major symptom outcome in breast cancer; however, little is known about its prevalence and risk factors among women receiving aromatase inhibitors (AIs), a standard treatment to increase disease-free survival among breast cancer patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 99 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 18%
Student > Bachelor 12 12%
Researcher 9 9%
Student > Ph. D. Student 8 8%
Other 7 7%
Other 9 9%
Unknown 36 36%
Readers by discipline Count As %
Medicine and Dentistry 23 23%
Nursing and Health Professions 10 10%
Psychology 7 7%
Agricultural and Biological Sciences 3 3%
Sports and Recreations 3 3%
Other 13 13%
Unknown 40 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2012.
All research outputs
#6,809,933
of 22,665,794 outputs
Outputs from Supportive Care in Cancer
#1,644
of 4,517 outputs
Outputs of similar age
#48,370
of 163,698 outputs
Outputs of similar age from Supportive Care in Cancer
#12
of 32 outputs
Altmetric has tracked 22,665,794 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 4,517 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,698 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.